T
SOPH icon

TCWP’s SOPHiA GENETICS SOPH Stock Holding History

TCWP’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30
Closed – – 1525
2022
Q1 		$0 Buy
+30
New +$337 ﹤0.01% 1895

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCWP's SOPH Position: Q2 2022 in Review

TCWP sold out of SOPHiA GENETICS (SOPH) in Q2 2022, closing a stake of 30 shares.

TCWP first reported a position in SOPH in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 34 funds tracked by Wall St. Rank hold SOPH as of Q2 2022.

  • TCWP reported no remaining SOPHiA GENETICS position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 30 SOPHiA GENETICS shares in Q2 2022.
  • TCWP first reported a position in SOPHiA GENETICS in Q1 2022 and held it in 1 quarter.
  • TCWP's SOPHiA GENETICS position peaked at $0 in Q1 2022.
  • 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.